Portfolio News

Man Visually Impaired for 17 Years Sees Girlfriend for the First Time and Proposes to Her

Brittney Reed and her boyfriend Hunter Tribe looking into each other’s eyes while he is wearing eSight glasses. Tribe has a degenerative eye condition called Stargardt's disease. This leads to near-total blindness where they can still see peripherally, but this sight is still hazy. This clueless boyfriend had no idea that his partner had written into the ""Rachael Ray"" show, which habitually helps those struggling with eyesight issues. She asked if they could help Tribe see with a pair of...
Read more...

Core vendors seek to eliminate barriers in bank-fintech partnerships

The Milford Bank is a 149-year-old community institution in Connecticut trying to attract a younger audience. But there are limits to how extensively it can enhance its technological capabilities in-house or research, test and integrate products from potential fintech partners. With the help of Fiserv, its core provider, the $550 million-asset bank incorporated into its offerings the services of FutureFuel.io, which helps users manage their student debt. Fiserv has been quietly engineering connections between its bank clients and fintechs that...
Read more...

The donation of sight

North Country Association for the Visually Impaired Executive Director Amy Kretser tries on a pair of Tina Leonard’s eSight glasses on Nov. 18. Leonard, a Lake Placid real estate broker who died in September at the age of 63, used the $10,000 glasses for a short time until she lost all of her sight. Kretser isn’t sure exactly how the eSight glasses will be used. Perhaps they will be a “demo” model for people who are visually impaired to try...
Read more...

What will tomorrow’s Covid-19 vaccines be like?

The first generation of Covid-19 vaccines was developed in record time. But now scientists have grander plans – for more potent immunity, easier transport, and mutation-proofing... While Zion, an entrepreneur and chief executive of a small start-up called Akston Biosciences, was personally relieved that the tide was turning against the global pandemic, he faced the unenviable task of trying to convince his employees that their hard graft had not been in vain. Read more >>
Read more...

The Boston Globe Names Wasabi Technologies a Top Place to Work for 2021

Wasabi Technologies, the hot cloud storage company, today announced it has been named one of the Top Places to Work in Massachusetts in the 14th annual employee-based survey project from The Boston Globe. The Top Places to Work 2021 issue publishes online at Globe.com/TopPlaces on the night of December 1 and in Globe Magazine on December 5. Read more >>
Read more...

ZetrOZ Systems Expands Patient Access for Sustained Acoustic Medicine Treatment

ZetrOZ's sam® is the only FDA-cleared, long-duration, home-use, ultrasound treatment system, with over 30 peer-reviewed studies showing it effectively increases nutrient transport, relieves pain, restores function, and returns patients back to work, sports and other daily activities. Its continuous ultrasound therapy promotes injury healing to deep tissue by inhibiting inflammation and increasing the rate of tissue regeneration, angiogenesis, and nutrient exchange. sam® was designed for easy, long-term home use. Read more >>
Read more...

Pyramid Biosciences’ $864 Million Licensing Deal

Clinical-stage biotechnology company Pyramid Biosciences, Inc. announced the development of a global licensing deal for two cancer therapies worth up to $846 million. The licensing agreement with South Korea-based biotechnology company Voronoi, Inc. will bring a novel monopolar spindle1 (MPS1) called VRN-08 and second undisclosed asset into Pyramid Bioscience’s portfolio of precision oncology therapeutics. MPS1 is involved in core-of-tumor cell division. The novel inhibitor VRN-08 selectively blocks this process, ultimately leading to tumor cell death. Founded in 2015, Waltham, Mass.-based...
Read more...

Groton biotech firm working on much-needed drug to treat stroke, brain injuries

A small drug development company that moved its headquarters from Cambridge, Mass., to the BioCT Innovations Commons on Shennecossett Road last year is aiming to have a huge impact on the treatment of strokes and brain injuries. Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022. Read more >>
Read more...

Wasabi Technologies and Nutanix Partner to Deliver Next-Gen Capacity Management and Analytics for Unstructured Data Storage

Wasabi Technologies, the hot cloud storage company, today announced that it has partnered with Nutanix, a leader in hybrid multicloud computing, to deliver a next-generation capacity management and analytics solution that meets the evolving needs for unstructured data storage. Through Nutanix Files supported integration of data tiering to Wasabi’s cloud object store, joint customers will be able to scale unstructured datasets on demand, deploy automated rules and triggers for efficient data management, and gain high-impact analytics and complete visibility across...
Read more...

Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)

Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M grant to support the development of its ISP-002 (for delivery of iduronate sulfatase) program in mucopolysaccharidosis type II (MPS II), an inherited disease for which patients have limited options. MPS II is a rare genetic disease in children, which causes...
Read more...